Laboratory Testing for Severe Hypertension with Headache
For a walk-in patient with severe hypertension (200/115 mm Hg) and headaches, order a comprehensive metabolic panel (sodium, potassium, creatinine with eGFR, glucose, calcium), complete blood count, urinalysis, and ECG immediately to assess for hypertensive emergency and screen for secondary causes. 1
Immediate Assessment Priority
This blood pressure qualifies as a hypertensive crisis (systolic >180 mm Hg or diastolic >120 mm Hg) and requires urgent evaluation to distinguish between hypertensive urgency versus emergency. 2 The presence of headache raises concern for potential end-organ damage (hypertensive encephalopathy, intracranial hemorrhage), making this a potential hypertensive emergency until proven otherwise. 2
Essential Basic Laboratory Tests
Core Metabolic Panel
- Serum sodium and potassium: Hypokalemia suggests primary aldosteronism or renovascular disease as secondary causes. 1
- Serum creatinine with estimated glomerular filtration rate (eGFR): Assesses for acute kidney injury or chronic kidney disease as both cause and consequence of severe hypertension. 1
- Fasting blood glucose: Screens for diabetes as a cardiovascular risk factor and potential contributor to resistant hypertension. 1
- Serum calcium: May be included in comprehensive metabolic panel. 1
Additional Basic Tests
- Complete blood count: Evaluates for anemia, thrombocytopenia (HELLP syndrome if applicable), or polycythemia. 1
- Urinalysis with dipstick: Screens for proteinuria, hematuria, and red blood cell casts indicating hypertensive nephropathy or glomerulonephritis. 1
- 12-lead ECG: Detects left ventricular hypertrophy, acute coronary syndrome, arrhythmias, or conduction abnormalities. 1
Optional Tests Based on Clinical Context
If Considering Secondary Hypertension
The following warrant additional testing in this severe presentation:
- Thyroid-stimulating hormone (TSH): Screens for hypo- or hyperthyroidism as reversible causes. 1
- Lipid profile: Completes cardiovascular risk stratification. 1
- Urinary albumin-to-creatinine ratio: More sensitive than dipstick for detecting early kidney damage. 1
Red Flags for Secondary Causes in This Patient
This patient's severe hypertension (200/115 mm Hg) itself is a red flag. 3, 4 Additional screening for secondary hypertension should be considered if:
- Age <30 years or sudden onset in previously normotensive patient 3, 5, 4
- Resistant hypertension (if already on ≥3 medications including a diuretic) 3, 5, 4
- Spontaneous or diuretic-induced hypokalemia on basic labs 3, 4
- Acute rise in creatinine >50% after starting ACE inhibitor/ARB 6
Algorithmic Approach to Laboratory Ordering
Step 1: Order immediately upon presentation:
- Comprehensive metabolic panel (includes sodium, potassium, creatinine, eGFR, glucose, calcium) 1
- Complete blood count 1
- Urinalysis 1
- ECG 1
Step 2: Add if results pending or patient stable enough for outpatient workup:
Step 3: If basic labs reveal hypokalemia, young age, or resistant hypertension:
Critical Pitfalls to Avoid
- Do not delay treatment while waiting for laboratory results if clinical signs of hypertensive emergency are present (altered mental status, chest pain, dyspnea, focal neurologic deficits). 2
- Do not assume essential hypertension without reviewing medication adherence and substance use (NSAIDs, decongestants, cocaine, amphetamines, oral contraceptives). 3, 4, 7
- Do not order extensive secondary hypertension workup before confirming medication adherence and excluding white-coat effect with home or ambulatory blood pressure monitoring. 3, 4
- Do not miss acute kidney injury: A rise in creatinine may indicate hypertensive nephrosclerosis, renovascular disease, or medication effect. 6
When to Consider Advanced Testing
If basic labs show hypokalemia (<3.5 mEq/L), proceed with aldosterone-to-renin ratio. 3, 4 If creatinine is elevated or urinalysis shows proteinuria/hematuria, consider renal ultrasound. 1 If patient is <30 years old or has abdominal bruit on exam, consider renovascular imaging. 3, 5
Evidence Strength
The 2017 ACC/AHA guidelines 1, 2020 ISH guidelines 1, and 2013 ESH/ESC guidelines 1 all consistently recommend this basic laboratory panel for initial hypertension evaluation, with the most recent 2024 ESC update now recommending aldosterone-to-renin ratio screening for all confirmed hypertension cases. 3, 4